Headlines about Ceres (NASDAQ:CERE) have been trending somewhat positive on Friday, according to Accern. Accern ranks the sentiment of press coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Ceres earned a coverage optimism score of 0.07 on Accern’s scale. Accern also gave media stories about the biotechnology company an impact score of 46.0029072782911 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
Here are some of the media stories that may have impacted Accern’s analysis:
- First Measure L pavement treatments applied (cerescourier.com)
- Patterson’s bats stay hot versus Ceres (goldenstatenewspapers.com)
- Showdown in court over Ceres evictions (groundup.org.za)
- 188 read to Ceres students (cerescourier.com)
- Ceres Centennial Gala draws 300 (cerescourier.com)
NASDAQ CERE remained flat at $$0.40 during trading hours on Friday. 182,300 shares of the company traded hands, compared to its average volume of 848,868. Ceres has a 12 month low of $0.16 and a 12 month high of $4.80.
Ceres, Inc is an agricultural biotechnology company that develops and markets seeds and traits to produce crops for feed, forages, sugar and other markets. The Company uses a combination of plant breeding, biotechnology and bioinformatics to develop seed products and biotechnology traits. Its Forage sorghum seeds are used for growing feed for livestock, including dairy and beef cattle.
Receive News & Ratings for Ceres Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceres and related companies with MarketBeat.com's FREE daily email newsletter.